A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
about
Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trialsExploiting cancer genomics in pet animals to gain advantage for personalized medicine decisions.Rapid learning for precision oncology.Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
P2860
A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
@en
type
label
A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
@en
prefLabel
A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
@en
P2093
P2860
P356
P1476
A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
@en
P2093
Anthony W Rusk
Craig P Webb
David M Cherba
Derrick Carter
Emily Eugster
Heather Simpson
Keith R Marotti
Marie Mooney
Matthew Steensma
Noel R Monks
P2860
P2888
P356
10.1186/1479-5876-11-158
P577
2013-07-01T00:00:00Z
P5875
P6179
1028734508